Jazzy, JZZ-001 @iMGSRC.RU
- arlberkhi
- Jan 29, 2022
- 1 min read
Dec 17, 2019 — In relapsed SCLC, lurbinectedin showed an ORR of 35.2%, which compares favorably to topotecan's historical ORR of 16.9%1 by investigator ...
Jazzy, JZZ-001 @iMGSRC.RU
3925e8d270
Comments